Related Experiment Videos
[Cardiovascular diseases and hormone replacement therapy in females]
1Semmelweis Orvostudományi Egyetem, Budapest, I. Belgyógyászati Klinika.
Insights
Hormone replacement therapy (HRT) significantly reduces the risk of heart disease and stroke in menopausal women. This therapy improves lipid profiles and impacts blood clotting factors, offering cardiovascular protection.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Vascular Biology
Context:
- Menopause is associated with increased cardiovascular and stroke risks.
- Hormone replacement therapy (HRT) is a common intervention during menopause.
- Understanding HRT's impact on cardiovascular health is crucial.
Purpose:
- To summarize the effects of HRT on ischaemic heart disease and stroke.
- To discuss the influence of oestrogen and combined therapies on cardiovascular risk factors.
- To explore potential direct vascular effects of HRT.
Summary:
- HRT, including oestrogen or combined oestrogen-gestagen therapy, positively affects lipid parameters.
- The therapy influences key factors of haemostasis, potentially reducing thrombotic risk.
- Evidence suggests HRT may exert direct beneficial effects on blood vessel function.
Impact:
- HRT in menopausal women significantly decreases morbidity and mortality from cardiovascular events and stroke.
- This highlights HRT as a protective strategy against major adverse cardiovascular outcomes.
- The findings support the role of HRT in managing menopausal women's long-term cardiovascular health.
Abstract:
The effects of hormone replacement therapy are summarized from the point of view of ischaemic heart disease and stroke syndrome. The beneficial effects of oestrogen or combined oestrogen-gestagen therapy on different lipid parameters, some factors of the haemostasis are discussed, as well as the possibilities of a direct effect on blood vessels. Hormone replacement therapy in the menopause significantly decreases cardiovascular and stroke morbidity and mortality.